tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market

Kymera Therapeutics (KYMR) Ownership - Who Owns Kymera Therapeutics?

Compare
222 Followers

Kymera Therapeutics (KYMR) Ownership Overview

19.98%30.55%0.75%13.00%35.71%
19.98% Insiders
0.75% Other Institutional Investors
13.00% ETFs
35.71% Public Companies and
Individual Investors
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 44.30% of the company’s stock is owned by Institutional Investors, 19.98% is owned by Insiders, and 35.71% is owned by Public Companies and Individual Investors.
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 31.30% of the company’s stock is owned by Institutional Investors, 19.98% is owned by Insiders, and 13.00% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 03, 2025
xxxxxxxxxxxxx
$214172
Mar 03, 2025
xxxxxxxxxxxxx
$68225
Mar 03, 2025
xxxxxxxxxxxxx
$174747
Mar 03, 2025
xxxxxxxxxxxxx
$42104

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$4842605
Dec 31, 2024
xxxxxxxxxxxxx
$13129020
Dec 31, 2024
xxxxxxxxxxxxx
$21620728
Dec 31, 2024
xxxxxxxxxxxxx
$23856390

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,995,929Institution9.23%150,018,144
5,995,929Insider9.23%150,018,144
5,054,898Insider7.78%126,473,548
4,621,153Institution7.12%115,621,248
4,185,317Institution6.44%104,716,631
3,093,981Institution4.76%77,411,405
2,547,968Institution3.92%63,750,159
2,351,428Institution3.62%58,832,729
2,198,895Institution3.39%55,016,353
1,390,372Institution2.14%34,787,107

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,185,317Institution6.44%104,716,631
3,093,981Institution4.76%77,411,405
2,547,968Institution3.92%63,750,159
2,351,428Institution3.62%58,832,729
1,369,813Institution2.11%34,272,721
1,036,819Institution1.60%25,941,211
605,059Institution0.93%15,138,576
499,404Institution0.77%12,495,088
458,836Institution0.71%11,480,077
455,728Institution0.70%11,402,315

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,536,767Institution2.37%48,177,645
1,236,991Institution1.90%49,764,148
1,196,839Institution1.84%29,944,912
737,776Institution1.14%18,783,777
721,056Institution1.11%22,605,106
701,597Institution1.08%27,776,225
423,991Institution0.65%10,608,255
344,355Institution0.53%8,615,762
221,372Institution0.34%5,636,131
214,628Institution0.33%6,728,588

FAQ

Who Owns Kymera Therapeutics (KYMR)?
According to the latest TipRanks data, approximately 0.75% of the company's stock is held by institutional investors, 19.98% is held by insiders, and 35.71% is held by retail investors.
    What percentage of Kymera Therapeutics (KYMR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.75% of Kymera Therapeutics (KYMR) stock is held by institutional investors.
      What percentage of Kymera Therapeutics (KYMR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 35.71% of Kymera Therapeutics (KYMR) stock is held by retail investors.
        Who owns the most shares of Kymera Therapeutics (KYMR)?
        Felix Baker owns the most shares of Kymera Therapeutics (KYMR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis